The Government of India is holding discussions with COVID-19 manufacturers Moderna and Pfizer over several issues including indemnity waiver, Dr VK Paul, Member (Health), NITI Aayog said on Friday.
Earlier, Dr VK Paul told ANI that government is in touch with the companies and holding discussions, "We are in touch with them. We are holding discussions. It is a process of negotiation and dialogues. We are trying to get a solution on contractual and commitments issues. This process is ongoing."
Keeping in view of the above developments, Dr Poonam Khetrapal Singh, Regional director of World Health Organisation (WHO) South East Asia told ANI that India has been offered 7.5 million doses of Moderna vaccine through Covax.
In June, US biotechnology company Moderna announced that India has granted permission for its COVID-19 vaccine to be imported into the country for restricted use in an emergency situation.
Pfizer has not even applied for an emergency use authorisation in the country.
Moderna and Pfizer had sought indemnity which would ensure that they can't be booked in case of any adverse effect of the vaccine.
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
"Making That Decision...": India Great's No-Nonsense Take On Rohit Sharma 'The Leader' "Virat Kohli's Wicket Was Huge": New Zealand Star Blunt Verdict "Not Just To Participate...": Former India Captain Anjum Chopra Gives Brutal 'Underprepared' Verdict On Harmanpreet Kaur-Led Side MK Stalin Asks Centre To Recall Tamil Nadu Governor In Row Over Anthem Delhi Ex Minister Satyendar Jain Leaves Jail, Chief Minister Greets Him "War Can End Tomorrow If...": Netanyahu's Message After Killing Of Yahya Sinwar Meta Launches AI That Can Monitor Other AI As Human Involvement Diminishes Israel Says Intercepts Suspicious 'Aerial Target' Approaching From Syria Cuba Plunges Into Countrywide Darkness As National Power Grid Fails Track Latest News Live on NDTV.com and get news updates from India and around the world.